Phase 1 Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE)

Clinical trial NCT00657007 · COMPLETED

Trial details

NCT number: NCT00657007
Sponsor: Human Genome Sciences Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus

Start date: 2002-02-01
Primary completion: 2003-03-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.